1. Home
  2. FTW vs ZVRA Comparison

FTW vs ZVRA Comparison

Compare FTW & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FTW

EQV Ventures Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$10.92

Market Cap

470.2M

Sector

Energy

ML Signal

N/A

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$10.36

Market Cap

472.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTW
ZVRA
Founded
2017
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
470.2M
472.9M
IPO Year
2024
2015

Fundamental Metrics

Financial Performance
Metric
FTW
ZVRA
Price
$10.92
$10.36
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$23.00
AVG Volume (30 Days)
111.2K
665.1K
Earning Date
N/A
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
159.21
EPS
N/A
1.35
Revenue
N/A
$106,470,000.00
Revenue This Year
N/A
$37.27
Revenue Next Year
N/A
$53.42
P/E Ratio
N/A
$7.65
Revenue Growth
N/A
350.91
52 Week Low
$9.50
$6.85
52 Week High
$17.20
$13.16

Technical Indicators

Market Signals
Indicator
FTW
ZVRA
Relative Strength Index (RSI) 48.82 64.60
Support Level $9.50 $8.29
Resistance Level $13.83 $11.19
Average True Range (ATR) 0.52 0.39
MACD -0.02 0.08
Stochastic Oscillator 53.31 88.68

Price Performance

Historical Comparison
FTW
ZVRA

About FTW EQV Ventures Acquisition Corp. Class A Ordinary Shares

EQV Ventures Acquisition Corp is a blank check company.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Share on Social Networks: